218 related articles for article (PubMed ID: 9126057)
1. Central nervous system pathology in patients with the Guillain-Barré syndrome.
Maier H; Schmidbauer M; Pfausler B; Schmutzhard E; Budka H
Brain; 1997 Mar; 120 ( Pt 3)():451-64. PubMed ID: 9126057
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory infiltrates in the spinal cord of patients with Guillain-Barré syndrome.
Müller HD; Beckmann A; Schröder JM
Acta Neuropathol; 2003 Dec; 106(6):509-17. PubMed ID: 13680278
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.
Griffin JW; Li CY; Ho TW; Xue P; Macko C; Gao CY; Yang C; Tian M; Mishu B; Cornblath DR
Brain; 1995 Jun; 118 ( Pt 3)():577-95. PubMed ID: 7600080
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review.
Honavar M; Tharakan JK; Hughes RA; Leibowitz S; Winer JB
Brain; 1991 Jun; 114 ( Pt 3)():1245-69. PubMed ID: 2065248
[TBL] [Abstract][Full Text] [Related]
5. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
6. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
[TBL] [Abstract][Full Text] [Related]
7. Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats.
Izumo S; Linington C; Wekerle H; Meyermann R
Lab Invest; 1985 Aug; 53(2):209-18. PubMed ID: 2410663
[TBL] [Abstract][Full Text] [Related]
8. Complementary contribution of CD4 and CD8 T lymphocytes to T-cell infiltration of the intact and the degenerative spinal cord.
Bradl M; Bauer J; Flügel A; Wekerle H; Lassmann H
Am J Pathol; 2005 May; 166(5):1441-50. PubMed ID: 15855644
[TBL] [Abstract][Full Text] [Related]
9. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms?
Feasby TE; Hahn AF; Brown WF; Bolton CF; Gilbert JJ; Koopman WJ
J Neurol Sci; 1993 Jun; 116(2):185-92. PubMed ID: 8336165
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural study of peripheral nerve in Guillain-Barré syndrome presence of mononuclear cells in axons.
Brechenmacher C; Vital C; Laurentjoye L; Castaing Y
Acta Neuropathol Suppl; 1981; 7():249-51. PubMed ID: 6939246
[TBL] [Abstract][Full Text] [Related]
11. B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis.
Reali C; Magliozzi R; Roncaroli F; Nicholas R; Howell OW; Reynolds R
Brain Pathol; 2020 Jul; 30(4):779-793. PubMed ID: 32243032
[TBL] [Abstract][Full Text] [Related]
12. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model.
George R; Griffin JW
Exp Neurol; 1994 Oct; 129(2):225-36. PubMed ID: 7957737
[TBL] [Abstract][Full Text] [Related]
13. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination.
Berciano J; Coria F; Montón F; Calleja J; Figols J; LaFarga M
Muscle Nerve; 1993 Jul; 16(7):744-51. PubMed ID: 8505931
[TBL] [Abstract][Full Text] [Related]
14. A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
Yang M; Rainone A; Shi XQ; Fournier S; Zhang J
Acta Neuropathol Commun; 2014 Jan; 2():5. PubMed ID: 24401681
[TBL] [Abstract][Full Text] [Related]
15. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome with ophthalmoplegia: clinicopathologic study of the central and peripheral nervous systems, including the oculomotor nerves.
Dehaene I; Martin JJ; Geens K; Cras P
Neurology; 1986 Jun; 36(6):851-4. PubMed ID: 3703295
[TBL] [Abstract][Full Text] [Related]
17. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.
Jarius S; Ringelstein M; Haas J; Serysheva II; Komorowski L; Fechner K; Wandinger KP; Albrecht P; Hefter H; Moser A; Neuen-Jacob E; Hartung HP; Wildemann B; Aktas O
J Neuroinflammation; 2016 Oct; 13(1):278. PubMed ID: 27776522
[TBL] [Abstract][Full Text] [Related]
18. A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes.
Kanda T; Hayashi H; Tanabe H; Tsubaki T; Oda M
J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):857-64. PubMed ID: 2769280
[TBL] [Abstract][Full Text] [Related]
19. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
[TBL] [Abstract][Full Text] [Related]
20. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.
Popovich PG; Yu JY; Whitacre CC
J Neuropathol Exp Neurol; 1997 Dec; 56(12):1323-38. PubMed ID: 9413281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
